BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16216722)

  • 1. Family history, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: A one-year follow-up study.
    Rizzo M; Barbagallo CM; Noto D; Pace A; Cefalú AB; Pernice V; Pinto V; Rubino A; Pieri D; Traina M; Frasheri A; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2005 Oct; 15(5):361-7. PubMed ID: 16216722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.
    Bair TL; Muhlestein JB; May HT; Meredith KG; Horne BD; Pearson RR; Li Q; Jensen KR; Anderson JL; Lappé DL
    Circulation; 2007 Sep; 116(11 Suppl):I226-31. PubMed ID: 17846308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of adverse events after percutaneous transluminal coronary angioplasty in a group of Hispanic patients.
    Padilla AJ; Vega RA; Lladó IJ; Conde JG
    P R Health Sci J; 2001 Mar; 20(1):5-11. PubMed ID: 11394217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State.
    Berger JS; Petersen JL; Brown DL
    Circ Cardiovasc Interv; 2009 Aug; 2(4):317-22. PubMed ID: 20031734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
    Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid and peripheral atherosclerosis in patients who underwent primary percutaneous coronary intervention and outcome associated with multifocal atherosclerosis.
    Romano G; Corrado E; Muratori I; Novo G; Andolina G; Cospite V; Evola S; Ciaramitaro GF; Di Vincenzo A; Farinella M; Rotolo A; Assennato P; Hoffmann E; Novo S
    Int Angiol; 2006 Dec; 25(4):389-94. PubMed ID: 17164746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization.
    Botto N; Andreassi MG; Rizza A; Berti S; Bevilacqua S; Federici C; Palmieri C; Glauber M; Biagini A
    Int J Cardiol; 2004 Sep; 96(3):341-5. PubMed ID: 15301885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of in-hospital mortality in women with acute myocardial infarction who underwent primary coronary angioplasty.
    Queirós MC; Pinto PF; Silva JC; Magalhães D; Garcia JM; Abreu-Lima C
    Rev Port Cardiol; 2000 Nov; 19(11):1157-61. PubMed ID: 11201631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of significant coronary artery disease in Turkish patients who undergo heart valve surgery.
    Sonmez K; Gencbay M; Akcay A; Yilmaz A; Pala S; Onat O; Duran NE; Degertekin M; Turan F
    J Heart Valve Dis; 2002 May; 11(3):431-7. PubMed ID: 12056739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cardiovascular outcomes following ischemic heart disease in patients with and without peripheral vascular disease.
    Nakata S; Yokoi Y; Matsumoto R; Shirai N; Otsuka R; Sugioka K; Yoshitani H; Ehara S; Kataoka T; Yoshiyama M
    Osaka City Med J; 2008 Jun; 54(1):21-30. PubMed ID: 18819262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina.
    Valenzuela LF; Vázquez R; Fournier JA; Cubero J; Maraví J; Cruz-Fernández JM; Kaski JC
    Int J Cardiol; 2007 Feb; 115(3):381-5. PubMed ID: 16814417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of high-density lipoproteins in the cardiology unit].
    Sampietro T; Bigazzi F; Dal Pino B; Landi P; Puntoni M; Minichilli F; Bianchi F; Chella E; Carpeggiani C; Bionda A
    Ital Heart J Suppl; 2004 Sep; 5(9):720-6. PubMed ID: 15568610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention.
    Kasai T; Miyauchi K; Kurata T; Okazaki S; Kajimoto K; Kubota N; Daida H
    Hypertens Res; 2008 Feb; 31(2):235-41. PubMed ID: 18360042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.